What changed from 1 April 2026

From 1 April 2026, Advice & Guidance stopped operating as a voluntary enhanced service and became part of routine contractual delivery in general practice. That means practices are expected to use it before, or instead of, a planned care referral where it is clinically appropriate.

Just as importantly, the separate claiming route has gone. There is no longer a stand-alone £20 payment attached to each request, so what was once a visible and traceable income stream has effectively been folded into wider contract funding. The practical effect is simple enough: the specific payment has disappeared, but the underlying activity has not.

For practices that had built consistent A&G use into their workflows, this changes both the financial picture and the operating model. What used to be optional and separately recognised is now embedded, expected, and much harder to isolate as a distinct workload line.

Why this matters now

National planning expectations point to a substantial increase in the use of Advice & Guidance over the next year. NHS planning direction includes a target for a quarter of planned care referrals to move through A&G pathways by March 2027 across at least ten high-volume specialties.

In reality, the impact will be shaped locally. Integrated Care Boards and provider organisations will determine which specialties become effectively “A&G-first” in each area, which means the pressure may arrive unevenly but is unlikely to be avoidable.

Local pathways matter more than ever

The contract shift is only one part of the story. The other part is pathway design. In many areas, practices will be expected to follow local referral routes that may include Single Point of Access arrangements and specialty triage before a patient is accepted for outpatient care.

In practical terms, that means a request may be assessed remotely and result in one of several outcomes: the patient is booked into specialist care, the practice receives written advice and is expected to continue management, or the case is redirected into a different route altogether.

This sounds efficient at system level, but the operational burden remains very real at practice level. A patient whose care is not taken on by secondary care does not vanish from the workload. The work simply stays closer to home.

Where the hidden workload actually sits

The real pressure point is what happens after the advice comes back. A response that says, in effect, “manage this in primary care” may save an outpatient slot, but it often creates a chain of follow-up tasks inside the practice.

That can include reviewing the advice, deciding how it applies to the patient in front of you, speaking to the patient about a changed expectation, arranging medication or tests, setting review points, documenting the plan, and deciding when re-referral becomes necessary.

This is why practices can underestimate the impact. The work is distributed across inboxes, tasks, prescriptions, investigations, patient communication, and documentation rather than appearing as a single obvious appointment event.

Governance and clinical responsibility

One of the most sensitive aspects of the new model is accountability. When a specialist declines to bring a patient into face-to-face secondary care but provides advice instead, the patient usually remains under the care of the GP practice. That means responsibility for implementation, follow-up, and documentation still sits locally.

This creates a grey zone that practices should not ignore. If clinicians feel that a patient still requires specialist assessment despite the advice returned, there needs to be a clear route for escalation. A process that assumes every A&G response must simply be accepted will eventually create trouble.

The safest approach is to formalise this internally: define who reviews incoming advice, how decisions are documented, when a clinician can override an unsuitable outcome, and how unresolved concerns are escalated. Good governance here is not bureaucracy. It is protection.

Why the funding question is still live

The obvious change is the end of the separate £20 payment. The less obvious issue is that activity may continue to rise while funding becomes less directly connected to volume. That matters because the burden on practices is not fixed. If more specialties adopt A&G-first pathways and more referrals are diverted, the time cost to practices can grow even if the funding mechanism does not.

For managers, the right question is not just how much payment disappeared. It is how much unfunded or under-recognised work is being absorbed as a result of the new arrangement. If you do not have a way of measuring that, the service will look lighter than it really is.

What practices should do now

Documentation, compliance, and audit trail

Every A&G interaction can generate additional records: the request itself, the specialist response, management instructions, coding, follow-up actions, prescriptions, investigations, and safety-netting notes. That is not a side issue. It is part of the workload.

For well-organised practices, this means more volume moving through existing systems. For less structured setups, it creates a higher risk of fragmented handling, incomplete records, and poor visibility of where work has landed. As A&G pathways expand, the quality of document handling and action tracking will matter more, not less.